�Ӱ���Ƶ

A Columbia University oncologist renowned for his translational research, mentoring and leadership will become director of the Case Comprehensive Cancer Center (Case CCC) this spring. Gary Schwartz, chief of the Hematology & Oncology Division at Columbia University Irving Medical Center (CUIMC) and...

Colon cancer pioneer and neural engineering innovator join nearly 20 others from �Ӱ���Ƶ in last decade on list �Ӱ���Ƶ researchers Sanford "Sandy" Markowitz and Dustin Tyler have been elected fellows of The National Academy of Inventors (NAI). The honor highlig...

In October, pink ribbons become a common sight as organizations promote breast cancer awareness. The goal of these efforts is to encourage those at risk of developing the disease to get mammograms in hopes of catching potential diagnoses early, when treatment is most effective. But despite efforts...

Nathan Berger has produced decades of biomedical research into cancer development and its associated risk factors. He is a nationally renowned authority on hematology and oncology and founding member of the Case Comprehensive Cancer Center, a consortium between �Ӱ���Ƶ, University Hospi...

The Case Comprehensive Cancer Center (Case CCC) recently announced it received a $2 million grant through the Alliance for Equity in Cancer Care (the Alliance), an initiative funded by the Merck Foundation (the Foundation) and designed to make cancer care more equitable in the United States by helpi...

September is National Sickle Cell Awareness Month, which aims to bring attention to advancing research, care practices, treatments and possible cures for people with sickle cell disease. Umut Gurkan To better understand this blood disorder, The Daily sat down with Umut Gurkan, a professor in the D...

Researchers say pathway is linked to tumor development Research led by �Ӱ���Ƶ has identified a promising path to developing therapies to treat esophageal tumors—a form of cancer that not only is among the most deadly, but also has been occurring at increasing rates over the...

Stanton Gerson, dean of the School of Medicine, shared his view on why 2022 is a breakthrough year in our battle against cancer in an op-ed published by Crain’s Cleveland Business. Titled “Personal View: A breakthrough year in the war on cancer,” Gerson’s piece described the role the Case Comprehen...

“Brilliant,” “dedicated” and “wonderful” are just a few of the words being used to describe revered �Ӱ���Ƶ School of Medicine faculty member Chris G. Dealwis, who passed away unexpectedly last weekend while visiting family in England. As a scientist, Dealwis’ groundbreakin...

Researchers at �Ӱ���Ƶ, University of Washington working to gain novel view of cancer, supported by $3.1 million National Institutes of Health grant Researchers at �Ӱ���Ƶ and the University of Washington expect to gain valuable new insights into highly aggressi...